0.7965
price down icon1.39%   -0.0112
after-market Handel nachbörslich: .80 0.0035 +0.44%
loading

Finanzdaten der Nextcure Inc-Aktie (NXTC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
15.92%
18.30
15.79 15.62 19.16 17.07
Operating Income/Loss
15.92%
-18.30
-15.79 -15.62 -19.16 -17.07
Income/Loss From Continuing Operations Before Tax
18.25%
-17.11
-14.47 -14.30 -17.86 -16.10
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.25%
-17.11
-14.47 -14.30 -17.86 -16.10
Net Income/Loss
18.25%
-17.11
-14.47 -14.30 -17.86 -16.10
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
127.14K%
27.90
0.0219 27.84 27.83 27.77
Diluted Average Shares
127.14K%
27.90
0.0219 27.84 27.83 27.77
Basic Earnings Per Share
17.31%
-0.61
-0.52 -0.51 -0.64 -0.58
Diluted Earnings Per Share
17.31%
-0.61
-0.52 -0.51 -0.64 -0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.41
price down icon 1.44%
$38.50
price up icon 7.27%
$371.28
price up icon 0.90%
$23.52
price up icon 6.43%
biotechnology ONC
$222.22
price up icon 1.61%
$115.17
price down icon 1.77%
Kapitalisierung:     |  Volumen (24h):